Abstract
We reviewed our experiences with concurrent chemoradiotherapy (CCRT) treatment for patients with resectable squamous cell carcinoma (SCC) of the larynx and considered the indication of CCRT for this malady. With early stage patients, the survival and the larynx preservation rates of stage I laryngeal SCC patients treated by radiotherapy alone were sufficient. CCRT for stage II laryngeal SCC patients was efficacious in improving the larynx preservation rate. With advanced stage patients, the treatment method including indication of CCRT may be determined by the contents of the chemotherapy and the TN staging of the laryngeal SCC. In our evaluation reports for the laryngeal functions in patients with laryngeal SCC treated with CCRT, it was concluded that laryngeal functions could be preserved in most cases after CCRT, though some hoarseness ensued after treatment and the tracheostoma could not be closed with some patients.
